Kisspeptin-10 in Canada: KISS1R Signalling and Lab Handling
Kisspeptin-10 is a small peptide with a surprisingly long list of ways to go wrong in the lab. Labs ordering kisspeptin-10 in Canada for receptor work need to know which species sequence they are receiving, whether the C-terminal amide is present, which assay suits a receptor that signals through calcium rather than cAMP, and why a response that fades over time is usually the receptor rather than the compound. This guide covers each of those for the scientists and QC staff who specify, receive and use the material, particularly when a project draws on many vials over several months.
Kisspeptin-10 in Canada: sequence and species variants
Kisspeptin-10 is a ten-residue, C-terminally amidated peptide. The human form is Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 (YNWNSFGLRF-NH2), formula C63H83N17O14, with an average mass of roughly 1,302.4 g/mol. The rat and mouse forms differ at a single position.
| Form | Final residue | Mass relative to human |
|---|---|---|
| Human | Phenylalanine amide | Reference, about 1,302.4 g/mol |
| Rat and mouse | Tyrosine amide | About 16 Da heavier, from the extra hydroxyl |
Both are active at their own species’ receptor and both are sold simply as kisspeptin-10. Pairing a rodent cell system with the human peptide can be a sound design, but only if someone chose it on purpose. Put the full sequence on the purchase order and confirm it against the certificate before any vial is opened.
Where the decapeptide comes from
The KISS1 transcript is translated into a precursor of 145 residues. Processing releases kisspeptin-54, and shorter forms of 14, 13 and 10 residues are also produced. All of them end in the same C-terminal stretch, and that shared tail carries what the receptor needs to recognise. Kisspeptin-10 is therefore the minimal fully active fragment, not a weakened shortcut. KISS1 was first described in cancer cell research as a metastasis-suppressor gene, which is why older papers refer to the longer product as metastin.
The shared tail has an analytical consequence. Because the fragments are chemically alike, they can elute close together on reversed-phase HPLC, so a retention time on its own does not prove which fragment is in the vial. Mass spectrometry separates them without ambiguity and should be part of identity confirmation.
Choosing an assay for a Gq-coupled receptor
The receptor, KISS1R (previously listed as GPR54), belongs to class A of the GPCRs and couples mainly to Gαq/11. Activation stimulates phospholipase C, producing inositol trisphosphate and a release of calcium from intracellular stores. That shapes the choice of readout:
- Calcium flux with a fluorescent indicator gives a fast, sensitive primary readout.
- Inositol phosphate accumulation, often measured as IP1, integrates signal over a longer window and is less sensitive to timing.
- ERK phosphorylation or beta-arrestin recruitment can be added where downstream or biased signalling is part of the question.
- cAMP assays, the default for many peptide receptors, are poorly suited here and can suggest inactivity that is really a mismatch of method.
Desensitisation and the time course
KISS1R desensitises strongly when agonist exposure is sustained. Under continuous stimulation, the receptor population responding at the end of an experiment is smaller than at the start, so a declining signal is the expected behaviour of the system. Reading that decline as peptide breakdown sends a lab looking for a storage problem that is not there.
When the goal is receptor pharmacology rather than desensitisation itself, pulsed stimulation with defined washout periods gives cleaner data. Report the pulse length and washout interval along with the concentration, because two groups using identical material under different stimulation patterns should not expect matching results.
Getting the peptide into solution and keeping it there
With tryptophan, two phenylalanines, leucine and tyrosine in ten residues, kisspeptin-10 has a substantial hydrophobic character, and it tends to aggregate at high concentration in neutral aqueous buffer. For analytical and in-vitro stocks, dissolving first in a slightly acidic solution or with a small share of organic co-solvent, then diluting into assay buffer, is the usual approach. A cloudy or slow-to-clear stock should be treated as a warning sign.
The opposite problem appears at the dilute end. At low working concentrations, a real fraction of the peptide can stick to tubes, tips and plates, and each step of a serial dilution in standard polypropylene may lose more than the arithmetic assumes. Low-binding plasticware limits the loss, as does adding a carrier protein to the diluent when the assay can tolerate it.
The two failure modes leave different fingerprints. Incomplete dissolution depresses the top of a concentration-response curve; surface adsorption distorts the bottom. If both ends look off, re-examine the stock before blaming the material.
The amide check and a receiving routine
The C-terminal amide is essential for activity at KISS1R. The free-acid form is far weaker and looks identical in the vial, in solubility and, in practice, on most HPLC traces. Mass is the reliable way to catch it, but the gap is only about one dalton, so the spectrum has to be read with that specific question in mind. Confirm that the calculated mass on the certificate is for the amidated sequence.
For a multi-vial order, a short routine keeps the paperwork and the stock aligned:
- Check the certificate sequence against the species you ordered, human phenylalanine or rodent tyrosine at the C-terminus.
- Confirm the stated mass corresponds to the amide.
- Match each vial’s cap and crimp colour to that certificate and log the pairing.
- Record lot, vial count and arrival condition, then move the lyophilised stock to cold, dark storage; tryptophan is light-sensitive.
- Where the project will run for months, request a single lot so that early and late experiments use the same material.
Kisspeptin-10 5 mg is third-party tested for purity by HPLC. Certificates are published for some products, and with mix-and-match volume pricing every vial in the cart counts toward the volume break, whether the order is one compound or several.
Kisspeptin-10 is sold for in-vitro laboratory research only. It is not for human or veterinary use, and this article does not describe or suggest any such use.
